Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
6.58
-0.49 (-6.93%)
At close: Jan 28, 2026, 4:00 PM EST
6.61
+0.03 (0.46%)
After-hours: Jan 28, 2026, 7:14 PM EST
Bicycle Therapeutics Employees
Bicycle Therapeutics had 305 employees as of December 31, 2024. The number of employees increased by 21 or 7.39% compared to the previous year.
Employees
305
Change (1Y)
21
Growth (1Y)
7.39%
Revenue / Employee
$92,915
Profits / Employee
-$821,836
Market Cap
456.44M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 305 | 21 | 7.39% |
| Dec 31, 2023 | 284 | 48 | 20.34% |
| Dec 31, 2022 | 236 | 117 | 98.32% |
| Dec 31, 2021 | 119 | 32 | 36.78% |
| Dec 31, 2020 | 87 | 15 | 20.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 368 |
| Kyverna Therapeutics | 129 |
| Niagen Bioscience | 104 |
| Solid Biosciences | 100 |
| Verastem | 78 |
| Zevra Therapeutics | 59 |
| Contineum Therapeutics | 41 |
| NovaBridge Biosciences | 32 |
BCYC News
- 16 days ago - Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026 - Business Wire
- 6 weeks ago - Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline - Business Wire
- 2 months ago - Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference - Business Wire
- 3 months ago - Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results - Business Wire
- 3 months ago - Bicycle Therapeutics: Looking For Their Niche, Addressing Cash Burn - Seeking Alpha
- 5 months ago - Bicycle Therapeutics Plc (BCYC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 5 months ago - Bicycle Therapeutics Strengthens Board of Directors with New Appointments - Business Wire
- 6 months ago - Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results - Business Wire